Wilmot Cancer Center Director Honored for Commitment to Research
James P. Wilmot Cancer Center Director Richard I. Fisher, M.D., a world expert in lymphoma research, was recently honored by the Lymphoma Research Foundation, the nation’s largest organization devoted to funding lymphoma research.
Fisher and three others received The Freundlich Leadership Award Oct. 6, at the Foundation’s annual gala in New York City. The award, one of the highest from the Foundation, was presented to leaders of its Scientific Advisory Board, which reviews funding requests and sets research priorities. The award was named for Barbara and Jerry Freundlich, the founders of Cure For Lymphoma, an organization that evolved into the Lymphoma Research Foundation.
Fisher is chair of the Scientific Advisory Board. He was recognized along with leaders from the Lombardi Comprehensive Cancer Center at Georgetown University, Frederick Hutchinson Cancer Research Center at the University of Washington, and The Cancer Institute of New Jersey.
Fisher is an internationally known expert in biological research and treatment of lymphoma. He is director of the University of Rochester Medical Faculty Group, senior associate dean for clinical affairs in the School of Medicine and Dentistry, as well as vice president of the University of Rochester Medical Center.
His research centers on the biology and treatment of lymphoma, cancers derived from white blood cells, and he has led national and international studies on Hodgkin’s disease and non-Hodgkin’s lymphoma.
Fisher is chairman of the Lymphoma Committee of the Southwest Oncology Group and is a member of the American Joint Committee on Cancer’s Lymphoma Task Force.
Author
